Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001140361-22-045712

Options or other derivatives

  • Chief Commercial Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lea Darrell Shane Chief Commercial Officer 2022-11-21 Grant or award · Stock option (right to buy) +100,000 100,000 D
Loading xslF345X03/form4.xml…